Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc > .

<< Previous

Bullboard Posts

Next >>

Comment by Dude51on Sep 30, 2021 11:36pm

228 Views

Post# 33950899

RE:RE:RE:RE:RE:RE:RE:.

I just read the study title and the date. I don't bash company's that I am trying to make money on. Not a shorter, just and investor who read a head line of an article and brought it to this boards attention. I am holding for $20.00 a share not 20 bucks for my whole investment.
This is the title that caught my attention:

"Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection"

Did I miss something?

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism